BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36446887)

  • 1. Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering.
    Mistry S; Gouripeddi R; Raman V; Facelli JC
    Diabetologia; 2023 Mar; 66(3):520-534. PubMed ID: 36446887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.
    Ng K; Stavropoulos H; Anand V; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Hagopian W; Achenbach P;
    Diabetes Care; 2022 Jan; 45(1):160-168. PubMed ID: 34758977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children.
    Salami F; Tamura R; You L; Lernmark Å; Larsson HE; Lundgren M; Krischer J; Ziegler AG; Toppari J; Veijola R; Rewers M; Haller MJ; Hagopian W; Akolkar B; Törn C;
    Pediatr Diabetes; 2022 Dec; 23(8):1586-1593. PubMed ID: 36082496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
    Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
    Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes.
    Nieto J; Castillo B; Astudillo M; Tosur M; Balasubramanyam A; Pietropaolo M; Redondo MJ
    Pediatr Diabetes; 2021 Sep; 22(6):882-888. PubMed ID: 34018301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants.
    Williams CL; Fareed R; Mortimer GLM; Aitken RJ; Wilson IV; George G; Gillespie KM; Williams AJK; ; Long AE
    Clin Exp Immunol; 2022 Dec; 210(2):151-162. PubMed ID: 36181724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.
    Pastore MR; Bazzigaluppi E; Bonfanti R; Dozio N; Sergi A; Balini A; Belloni C; Meschi F; Bonifacio E; Bosi E
    Diabetes Care; 1998 Sep; 21(9):1445-50. PubMed ID: 9727889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.
    Achenbach P; Warncke K; Reiter J; Naserke HE; Williams AJ; Bingley PJ; Bonifacio E; Ziegler AG
    Diabetes; 2004 Feb; 53(2):384-92. PubMed ID: 14747289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
    Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
    Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.